In the article you say, "The ivermectin–gemcitabine combination increased apoptosis of pancreatic cancer cells via ROS-induced mitochondrial dysfunction." Then, the protocol recommends VIR-X, which down below says that is provides antioxidant support. Is your antioxidant working against your ROS?
In the article you say, "The ivermectin–gemcitabine combination increased apoptosis of pancreatic cancer cells via ROS-induced mitochondrial dysfunction." Then, the protocol recommends VIR-X, which down below says that is provides antioxidant support. Is your antioxidant working against your ROS?
In the article you say, "The ivermectin–gemcitabine combination increased apoptosis of pancreatic cancer cells via ROS-induced mitochondrial dysfunction." Then, the protocol recommends VIR-X, which down below says that is provides antioxidant support. Is your antioxidant working against your ROS?